 |
Belinostat |
|---|---|
| Trade Name | Beleodaq |
| Orphan Indication | T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2009-09-03 00:00:00 |
| Sponsor | Spectrum Pharmaceuticals, Inc.;157 Technology Drive;Irvine, California, 92618 |
| |
Belinostat |
|---|---|
| Trade Name | Beleodaq |
| Orphan Indication | T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2009-09-03 00:00:00 |
| Sponsor | Spectrum Pharmaceuticals, Inc.;157 Technology Drive;Irvine, California, 92618 |